
Inveready backs Transbiomed
Venture capital firm Inveready Seed Capital has invested $1.2m in a first round of finance in biotechnology company Transbiomed.
The Department of Science and Innovation as well as ACC1Ó, an agency set up by the Catalan government to support Catalan enterprises, also participated in this round.
Transbiomed was founded in 2007 following a spin-off of Vall d'Hebrón Research Institute. The company has developed an appliance for the detection of prostate cancer. The device could be commercialised before the end of 2013.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater